Alkermes ALKS Total debt

Total debt at other companies

Bristol-Myers SquibbBMY

$43.33B-12.3%

Jazz PharmaceuticalsJAZZ

$5.4B-0.1%

AbbVieABBV

$62.36B+1.8%

Axsome TherapeuticsAXSM

$219.9M+4.1%

Indivior Pharmaceuticals, Inc.INDV

$509M+37.6%

LBR

LB Pharmaceuticals IncLBRX

$3.47M—

FAQ

What is Alkermes's total debt?

Alkermes (ALKS) reported total debt of $1.57B in Q2 2026.

How has Alkermes's total debt changed year-over-year?

Alkermes's total debt increased by 2063.7% year-over-year, from $72.68M to $1.57B.

What is the long-term trend for Alkermes's total debt?

Over 5 years (2020 to 2025), Alkermes's total debt has grown at a -29.8% compound annual growth rate (CAGR), from $410.16M to $70M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.